SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-289829
Filing Date
2021-10-01
Accepted
2021-10-01 17:01:10
Documents
15
Period of Report
2021-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d197369d8k.htm   iXBRL 8-K 29071
2 EX-1.1 d197369dex11.htm EX-1.1 194606
3 EX-5.1 d197369dex51.htm EX-5.1 9258
7 GRAPHIC g197369g1001080840496.jpg GRAPHIC 2332
  Complete submission text file 0001193125-21-289829.txt   418789

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cue-20211001.xsd EX-101.SCH 2901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20211001_lab.xml EX-101.LAB 18123
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20211001_pre.xml EX-101.PRE 11412
8 EXTRACTED XBRL INSTANCE DOCUMENT d197369d8k_htm.xml XML 3337
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 211299756
SIC: 2834 Pharmaceutical Preparations